PROLONGATION OF AMBULATION IN CHILDREN WITH DUCHENNE MUSCULAR-DYSTROPHY BY SUBCUTANEOUS LOWER-LIMB TENOTOMY

被引:21
作者
SMITH, SE
GREEN, NE
COLE, RJ
ROBISON, JD
FENICHEL, GM
机构
[1] Departments of Orthopaedic Surgery and Neurology, Vanderbilt University Medical Center, Nashville, TN
关键词
CONTRACTURES; MUSCULAR DYSTROPHY; TENOTOMIES;
D O I
10.1097/01241398-199305000-00012
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
To assess the effect of subcutaneous (s.c.) lower limb tenotomies on the ambulatory ability of patients with Duchenne muscular dystrophy (DMD), 54 patients were followed. Twenty-nine patients underwent hip, knee, and ankle tenotomies at a mean age of 10 2/12 years and were followed postoperatively for an average of 3 9/12 years. These children continued ambulation in long-leg braces to a mean age of 12 8/12 years and stood to an average of 13 5/12 years. Contracture correction was 49% at the hip, 58% at the knee, and 100% at the ankle. A separate group of 25 children to whom operation was offered but declined, was followed: these children ceased ambulating at a mean age of 10 years and ceased standing at a mean age of 10 2/12 years. Thus, we propose that s.c. tenotomy is effective in allowing braced ambulation well beyond what the natural history would allow.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 27 条
  • [1] Allsop G., Zilcr F.A., Loss of strength and functional decline in Duchenne's dystrophy, Arch Neurol, 38, pp. 406-411, (1981)
  • [2] Archibald K.C., Vignos P.J., A study of contractures in muscular dystrophy, Arch Phys Med Rehubil, 40, pp. 150-157, (1959)
  • [3] Bowker J.H., Halpin P.J., Factors determining success in re-ambulation of the child with progressive muscular dystrophy, Orthop Clin North Am, 9, pp. 431-436, (1978)
  • [4] Brooke M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B., Pellegrino R.J., Clinical trial in Duchenne dystrophy: 1. The design of the protocol, Muscle Nerve, 4, (1981)
  • [5] Brooke M.H., Fenichel G.M., Griggs R.C., Mendell J.R., Moxley R., Florence J., King W.M., Pandya S., Robison J., Schierbecker J., Signore L., Miller J.P., Gilder B.F., Kaiser K.K., Man-Del S., Arfken C., Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy, Neurology, 39, pp. 465-475, (1989)
  • [6] Eyring E.J., Johnson E.W., Burnett C., Surgery in muscular dystrophy, JAMA, 222, pp. 1056-1058, (1972)
  • [7] Fenichel G.M., Robison J.D., Update: Duchenne dystrophy, Comp Ther, 14, pp. 29-32, (1988)
  • [8] Fowler W.M., Rehabilitation management of muscular dystrophy and related disorders: 11. Comprehensive care, Arch Phys Med Rehubil, 63, pp. 322-328, (1982)
  • [9] Gardner-Medwin D., Objectives in the management of Duchenne muscular dystrophy, Isr J Med Sei, 13, pp. 229-234, (1977)
  • [10] Green N.E., The orthopaedic care of children with muscular dystrophy, Instr Course Led, 37, pp. 267-274, (1988)